The USTR launched a Section 301 investigation into Germany over pharmaceutical pricing, threatening tariffs up to 100% on patented drug imports from the EU.

America has started a trade probe into Germany's plan to cut pharmaceutical spending. U.S. Trade Representative Jamieson Greer stated the investigation will determine if Germany's…

The US Trade Representative said a new probe would determine if Germany was a underpaying for pharmaceuticals.